Akebia Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of AKBA for the last quarter is 32.61 M USD, and it's 41.98% lower compared to the previous quarter. The net income of Q1 24 is -17.98 M USD.